Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Lopez

Showing results (381-390 of 459) with videos related to

Pageof 46
Sort By:
Bioorganic & Medicinal Chemistry Letters|August 20, 2011
Discovery and characterization of potent and selective 4-oxo-4-(5-(5-phenyl-1,2,4-oxadiazol-3-yl)indolin-1-yl)butanoic acids as S1P₁ agonistsDaniel Buzard, Sangdon Han, Lars Thoresen, et al.
Cancers|February 11, 2023
Liver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center ExperienceDaniel Aliseda, Pablo Martí-Cruchaga, Gabriel Zozaya, et al.
Frontiers in Microbiology|December 6, 2019
Antifungal Activity of a Hydroethanolic Extract From <i>Astronium urundeuva</i> Leaves Against <i>Candida albicans</i> and <i>Candida glabrata</i>Bruna Vidal Bonifácio, Taissa Vieira Machado Vila, Isadora Fantacini Masiero, et al.
Journal of the American Heart Association|February 25, 2025
Sex Differences in Psychosocial Factors and Angina in Patients With Chronic Coronary DiseaseAnaïs Hausvater, Rebecca Anthopolos, Alexa Seltzer, et al.
The American Journal of Medicine|May 12, 2020
Comparison of Dabigatran Plus a P2Y<sub>12</sub> Inhibitor With Warfarin-Based Triple Therapy Across Body Mass Index in RE-DUAL PCIRaffaele De Caterina, Antonio Procopio, José-Luis Lopez Sendon, et al.
Cancers|February 13, 2020
Uncovering Tumour Heterogeneity through PKR and nc886 Analysis in Metastatic Colon Cancer Patients Treated with 5-FU-Based ChemotherapyMaría Belén Ortega-García, Alberto Mesa, Elisa L J Moya, et al.
American Heart Journal|May 22, 2025
Use of coronary artery bypass graft surgery and percutaneous coronary intervention and associated outcomes in the ISCHEMIA trialHarvey D White, Sean M O'Brien, William E Boden, et al.
Journal of Alzheimer'S Disease : JAD|June 23, 2009
On the diagnosis of CADASILIsrael Ampuero, Javier Alegre-Abarrategui, Izaskun Rodal, et al.
The Lancet. Haematology|November 29, 2016
Switching to nilotinib versus imatinib dose escalation in patients with chronic myeloid leukaemia in chronic phase with suboptimal response to imatinib (LASOR): a randomised, open-label trialJorge E Cortes, Carmino Antonio De Souza, Manuel Ayala, et al.
Cancers|December 30, 2025
Complications of Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-A Prospective Study on Behalf of the EBMT Transplant Complications Working PartyAgnieszka Tomaszewska, Grzegorz W Basak, Christophe Peczynski, et al.
Pageof 46

Showing results (381-390 of 459) with videos related to

Sort By:
Pageof 46
Bioorganic & Medicinal Chemistry Letters|August 20, 2011
Discovery and characterization of potent and selective 4-oxo-4-(5-(5-phenyl-1,2,4-oxadiazol-3-yl)indolin-1-yl)butanoic acids as S1P₁ agonistsDaniel Buzard, Sangdon Han, Lars Thoresen, et al.
Cancers|February 11, 2023
Liver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center ExperienceDaniel Aliseda, Pablo Martí-Cruchaga, Gabriel Zozaya, et al.
Frontiers in Microbiology|December 6, 2019
Antifungal Activity of a Hydroethanolic Extract From <i>Astronium urundeuva</i> Leaves Against <i>Candida albicans</i> and <i>Candida glabrata</i>Bruna Vidal Bonifácio, Taissa Vieira Machado Vila, Isadora Fantacini Masiero, et al.
Journal of the American Heart Association|February 25, 2025
Sex Differences in Psychosocial Factors and Angina in Patients With Chronic Coronary DiseaseAnaïs Hausvater, Rebecca Anthopolos, Alexa Seltzer, et al.
The American Journal of Medicine|May 12, 2020
Comparison of Dabigatran Plus a P2Y<sub>12</sub> Inhibitor With Warfarin-Based Triple Therapy Across Body Mass Index in RE-DUAL PCIRaffaele De Caterina, Antonio Procopio, José-Luis Lopez Sendon, et al.
Cancers|February 13, 2020
Uncovering Tumour Heterogeneity through PKR and nc886 Analysis in Metastatic Colon Cancer Patients Treated with 5-FU-Based ChemotherapyMaría Belén Ortega-García, Alberto Mesa, Elisa L J Moya, et al.
American Heart Journal|May 22, 2025
Use of coronary artery bypass graft surgery and percutaneous coronary intervention and associated outcomes in the ISCHEMIA trialHarvey D White, Sean M O'Brien, William E Boden, et al.
Journal of Alzheimer'S Disease : JAD|June 23, 2009
On the diagnosis of CADASILIsrael Ampuero, Javier Alegre-Abarrategui, Izaskun Rodal, et al.
The Lancet. Haematology|November 29, 2016
Switching to nilotinib versus imatinib dose escalation in patients with chronic myeloid leukaemia in chronic phase with suboptimal response to imatinib (LASOR): a randomised, open-label trialJorge E Cortes, Carmino Antonio De Souza, Manuel Ayala, et al.
Cancers|December 30, 2025
Complications of Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-A Prospective Study on Behalf of the EBMT Transplant Complications Working PartyAgnieszka Tomaszewska, Grzegorz W Basak, Christophe Peczynski, et al.
Pageof 46